Health News Releases

  • Today November 9
NJ Bio, Inc. now offers translational research services after completing asset purchase and full int
November 07, 11:30
NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P® Services
NJ Bio, Inc., a premier contract research and clinical manufacturing service provider in Princeton, New Jersey has announced the asset purchase and full integration of the research services of L2P Res
Representatives from the Local Content & Government Procurement Authority (LCGPA) and Boston Oncolog
November 07, 10:10
BOSTON ONCOLOGY ARABIA and LOCAL CONTENT & GOVERNMENT PROCUREMENT AUTHORITY Sign Agreement to Localize Advanced Biologic Medicines in Saudi Arabia
In a major step toward advancing pharmaceutical local content and national drug security, BOSTON ONCOLOGY ARABIA and the Local Content & Government Procurement Authority (LCGPA) have signed an agreeme
November 07, 09:50
Merz Aesthetics® Announces New Arms and Abdomen* Indication for Ultherapy PRIME, the Only FDA-Cleared Ultrasound With Real-Time Visualization
Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the U.S. Food and Drug Administration (FDA) clearance of Ultherapy PRIME to improve the appearance of skin l
November 05, 16:10
Galderma Receives U.S. FDA Approval for Restylane® Lyft™ for the Enhancement of the Chin Profile
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Restylane Lyft with Lidocaine for augment
November 05, 11:50
Merz Aesthetics® Introduces New BELOTERO® Syringe Offering Greater Precision, Comfort and Ease of Use
Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the launch of a new syringe for its category-leading hyaluronic acid (HA) brand BELOTERO®. The new syringe i
November 04, 08:39
New Phase 3 Data Show Takeda’s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54348492&newsitemid=20251030478402&lan=en-US&anchor=TSE%3A4
Kyung-Ah Kim will serve as the President and Chief Executive Officer (CEO) of Samsung Epis Holdings,
November 03, 11:44
Newly Established Samsung Epis Holdings to Drive Growth for Samsung Bioepis and a New Subsidiary
Samsung Epis Holdings Co., Ltd. today announced its establishment as a new investment holding company, following the spin-off of Samsung Bioepis Co., Ltd. from Samsung Biologics (KRX: 207940.KS). Sams
October 31, 10:40
Novotech Maps Global Growth in Radiopharmaceutical Trials
Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, today released a new white paper detailing the rapid rise of therapeutic radiopharmaceutical research a
October 31, 10:15
Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory
Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, today announced that its Suzhou, China
October 30, 16:51
Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year
Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54345580&newsitemid=20251029831616&lan=en-US&anc
October 30, 16:30
SS&C Introduces AI Agents to Simplify Financial Services and Healthcare Operations
SS&C Technologies Holdings, Inc. (https://www.ssctech.com/?utm_campaign=SSC2025-Enterprise-Press-Release-1025&utm_medium=pressrelease&utm_source=prnews&utm_content=SSNC-AI-Agents) (Nasdaq: SSNC) today
October 30, 16:20
Swiss Rockets Announces Strategic Exclusive License Acquisition of Cutting-Edge Sequencing Technology from MGI Tech and Complete Genomics
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement with MGI Tech and Complete Genomics, USA, granting Swiss Rockets a perpetual,
ONEWAYLAB team member demonstrating the company’s flagship device to visitors at the Beautyworld Mid
October 30, 13:52
ONEWAYLAB Expands Global Presence with Cutting-Edge Beauty Tech at Beautyworld Middle East 2025
ONEWAYLAB Co., Ltd. announced its participation in Beautyworld Middle East 2025, one of the world’s leading exhibitions for the beauty and wellness industries, held in Dubai. Certified as an offici
October 30, 09:00
Ferring Pharmaceuticals to Explore Strategic Options for Rebyota®
As part of our ongoing transformation to sharpen our focus, we have decided to explore strategic options for Rebyota® (faecal microbiota, live - jslm). To date, more than five thousand patients suffer
October 29, 10:55
SK pharmteco Achieves Highest-Level My Green Lab Certifications Across Europe and Asia
SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced a significant milestone in its commitment to environmental sustainability by earning four My Green La
Professor Nguyen Thanh Liem, Director, Institute of Stem Cell and Genetic Technology Research at Vin
October 28, 15:30
Colorectal, Liver, and Lung Cancer Patients at Vinmec Experience Extended Survival with AIET Cell-Based Immunotherapy - Technology Transferred from Japan
Significantly extended survival and improved quality of life (QoL) for cancer patients achieved through autologous cell-based AIET immunotherapy (https://www.immunotreatment.org/), utilizing patients'
Signing ceremony for the exclusive distribution agreement of the Wholemom artificial insemination so
October 27, 08:00
NURI SCIENCE Expands into Latin American Market through Exclusive Partnership in Paraguay
NURI SCIENCE Inc., a biotechnology company specializing in livestock reproduction technology, has signed an exclusive distribution agreement with Buenos Negocios S.A., a leading agricultural and lives
FACTS Logo
October 26, 11:15
Berry Consultants Releases FACTS 8 Clinical Trial Simulator
Berry Consultants, LLC announced the release of FACTS 8 (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.berryconsultants.com%2Fsoftware%2Fchangelog&esheet=54344231&newsitemid=20
October 24, 15:50
AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for “Bubble Baby Disease”
AGC Biologics, your friendly CDMO expert, today announced an agreement with Rarity PBC to provide comprehensive development and Good Manufacturing Practice (GMP) manufacturing for Rarity’s gene therap
October 23, 17:35
BeOne Medicines Presents New Data on TEVIMBRA in Lung Cancer at ESMO 2025
BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54341613&newsitemid=20251020512177&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5
October 23, 16:58
Galderma Delivers Record Net Sales of 3.737 Billion USD in the First Nine Months of 2025 and 15.0% Year-on-Year Growth at Constant Currency, Raises Full-Year Guidance
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the first nine months of 2025, delivering record net sales along with strong commerci
October 23, 15:00
Hologic to be Acquired by Blackstone and TPG for up to $79 per Share
Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds managed by Blackstone (“Blackstone”) and TPG in a transaction valued at up to $79 p
Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital
October 23, 14:10
Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital
Wilmington PharmaTech (“WPT”), a U.S.-based specialty contract research, development, and manufacturing organization (CRDMO) focused on custom small molecule API development and manufacturing, today a
HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics
October 23, 11:40
HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members
HistoSonics (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fhistosonics.com%2F&esheet=54343102&newsitemid=20251022130560&lan=en-US&anchor=HistoSonics&index=1&md5=40fd847d883559ad8d0
Rigaku Technology Taiwan Co., Ltd., located in Tai Yuen Hi-Tech Industry Park
October 22, 17:15
Rigaku opens Rigaku Technology Center Taiwan
Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) hereby announces the establishment of Rigaku Technology Taiwan Co., Ltd. (hereinafter “RTTW”), a ne
25 per page50 per page75 per page100 per page